Literature DB >> 17531424

Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry.

Wenyan Hua1, Li Ding, Yan Chen, Bin Gong, Jianchang He, Guili Xu.   

Abstract

A liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) method for the determination of berberine in human plasma using chlorobenzylidine as the internal standard (IS) has been developed and validated. The plasma samples were prepared by LLE and the analytes were chromatographically separated on a Hanbon Lichrospher 5-C18 HPLC column under gradient elution with a mobile phase consisted of acetonitrile and 10mm ammonium acetate buffer containing 0.1% formic acid. Berberine was determined with electrospray ionisation-mass spectrometry (ESI-MS). LC-ESI-MS was performed in the selected-ion monitoring (SIM) mode using target ions at M(+)m/z 336.1 for berberine and M(+)m/z 464.1 for the IS. Calibration curve was linear over the range of 0.020-3.0 ng/ml. The lower limit of quantification (LLOQ) was 0.020 ng/ml. The intra- and inter-run variability values were less than 6.7 and 7.7%, respectively. The method has been successfully applied to determine the plasma concentration of berberine in healthy Chinese volunteers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531424     DOI: 10.1016/j.jpba.2007.03.022

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  39 in total

1.  Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats.

Authors:  Wei Chen; Yu-Qiang Miao; Dong-Jiao Fan; Shen-Shen Yang; Xia Lin; Ling-Kuo Meng; Xing Tang
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

2.  In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.

Authors:  Lin Cong; Yong Liao; Suteng Yang; Rongya Yang
Journal:  Mycopathologia       Date:  2017-01-31       Impact factor: 2.574

Review 3.  Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.

Authors:  Junli Ma; Qihang Zhou; Houkai Li
Journal:  Nutrients       Date:  2017-10-16       Impact factor: 5.717

Review 4.  Biologically active isoquinoline alkaloids covering 2014-2018.

Authors:  Xiao-Fei Shang; Cheng-Jie Yang; Susan L Morris-Natschke; Jun-Cai Li; Xiao-Dan Yin; Ying-Qian Liu; Xiao Guo; Jing-Wen Peng; Masuo Goto; Ji-Yu Zhang; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2020-07-29       Impact factor: 12.944

5.  CYP2D plays a major role in berberine metabolism in liver of mice and humans.

Authors:  Ying Guo; Feng Li; Xiaochao Ma; Xingguo Cheng; Honghao Zhou; Curtis D Klaassen
Journal:  Xenobiotica       Date:  2011-07-25       Impact factor: 1.908

6.  Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail.

Authors:  James T Nguyen; Dan-Dan Tian; Rakshit S Tanna; Deena L Hadi; Sumit Bansal; Justina C Calamia; Christopher M Arian; Laura M Shireman; Bálint Molnár; Miklós Horváth; Joshua J Kellogg; Matthew E Layton; John R White; Nadja B Cech; Richard D Boyce; Jashvant D Unadkat; Kenneth E Thummel; Mary F Paine
Journal:  Clin Pharmacol Ther       Date:  2020-12-23       Impact factor: 6.875

7.  Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.

Authors:  Ying Wang; Haiyi Liu; Miaoyan Zheng; Yanhui Yang; Huizhu Ren; Yan Kong; Shanshan Wang; Jingyu Wang; Yingying Jiang; Juhong Yang; Chunyan Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-07       Impact factor: 5.555

8.  Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes.

Authors:  Yi Li; Gang Ren; Yan-Xiang Wang; Wei-Jia Kong; Peng Yang; Yue-Ming Wang; Ying-Hong Li; Hong Yi; Zhuo-Rong Li; Dan-Qing Song; Jian-Dong Jiang
Journal:  J Transl Med       Date:  2011-05-15       Impact factor: 5.531

9.  Metabolic Interaction of the Active Constituents of Coptis chinensis in Human Liver Microsomes.

Authors:  Songcan Liu; Xinfeng Zhang; Furong Qiu; Ping Miao; Shujiao Shen; Leilei Zhu; Jin Zeng; Jian Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-06       Impact factor: 2.629

10.  Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats.

Authors:  Xu Zhang; Yufeng Zhao; Menghui Zhang; Xiaoyan Pang; Jia Xu; Chaoying Kang; Meng Li; Chenhong Zhang; Zhiguo Zhang; Yifei Zhang; Xiaoying Li; Guang Ning; Liping Zhao
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.